Pines City Colleges

(Owned and operated by THORNTON`S INTERNATIONAL STUDIES, INC.)
Magsaysay Ave. Baguio City 2600

College of Nursing

DRUG STUDY

Submitted to: Ms. Marjorie Ilonen

Submitted by: Shannon Cabfit

December 06, 2022

BETAHISTINE

NAME OF DRUG MODE OF ACTION INDICATION

Generic Name: Betahistine was found to have a Meniere’s disease, Meniere-like
Serc histamine-like action in animals. syndrome (with symptoms of
Since parenteral histamine has vertigo, tinnitus, and
Brand Name: been used in the treatment of sensorineural deafness), and
Betahistine dihydrochloride Meniere's disease, studies were vertigo of peripheral origin.
conducted to test the action of
Classification: betahistine in this condition.
Anti emetics and Anti vertigo Unlike some other anti-vertigo
drugs, testing with nystagmus
Dosage: induced by caloric and
rotational stimulation has
Route: demonstrated that betahistine
does not decrease the
vestibular response, as
recorded by
electronystagmography.
However, clinical studies
indicate that SERC may be
useful in reducing the vertigo of
Meniere's disease.
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Previous hypersensitive Occasionally patients have Avoid contact of oral solution or
reaction to the drug experienced gastric upset, injection with skin
components nausea and headache, Urticaria,
Pruritus, False heartbeat, Raise bed rails, institute safety
Insomnia measures, supervise ambulation

Advise relatives to support

patient’s ambulation

CINNARIZINE

NAME OF DRUG MODE OF ACTION INDICATION

Brand Name: Cinnarizine inhibits contractions Maintenance therapy for
Stugeron Forte of vascular smooth muscle cells symptoms of labyrinthine
by blocking L-type and T-type disorders, including vertigo,
Generic Name: voltage-gated calcium channels. dizziness, tinnitus, nystagmus,
Cinnarizine Cinnarizine has also been nausea, and vomiting
implicated in binding to
Classification: dopamine D2 receptors,
Anti vertigo histamine H1 receptors, and
muscarinic acetylcholine
Dosage: receptors.
Route:
Oral
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Patients with known Significant: Epigastric As with other antihistamines,
hypersensitivity to cinnarizine discomfort, drowsiness; new- cinnarizine may cause epigastric
onset or aggravation of distress; taking it after meals
parkinsonian symptoms. may diminish gastric irritation.
Gastrointestinal disorders:
Nausea, vomiting, dry mouth. Cinnarizine may cause
General disorders and somnolence, especially at the
administration site conditions: start of treatment. Therefore,
Fatigue. caution should be taken when
Immune system disorders: A alcohol or CNS depressants are
hypersensitivity reaction. used concomitantly
Investigations: Increased
weight.
Nervous system disorders:
Headache.
Psychiatric disorders:
Hypersomnia.
Skin and subcutaneous tissue
disorders: Hyperhidrosis,
lichenoid keratosis (including
lichen planus).

METOCLOPRAMIDE

NAME OF DRUG MODE OF ACTION INDICATION

Brand Name: Stimulates motility of the upper Symptomatic treatment of
Reglan GI tract. diabetic gastroparesis,
Blocks dopamine/serotonin placement of enteral feeding
Generic Name: receptors in the chemoreceptor tubes, prevent/treat
Metoclopramide trigger zone. nausea/vomiting with
Enhances acetylcholine chemotherapy or after surgery.
Classification: response in upper GI tract;
Dopamine receptor antagonist increases lower esophageal
sphincter tone.
Dosage:
10mg

Route:
IVTT
CONTRAINDICATION
Concurrent use of medications
likely to produce extrapyramidal
reactions, GI hemorrhage, GI
obstruction/perforation, History
ADVERSE EFFECT
Drowsiness, restlessness,
fatigue, lethargy, dizziness,
anxiety, headache, insomnia,
breast tenderness, altered
NURSING RESPONSIBILITIES
Assess for dehydration (poor
skin turgor, dry mucous
membranes, longitudinal
furrows in tongue).
of seizure disorder, and
Pheochromocytoma.
Cautions: Renal impairment, HF,
cirrhosis, hypertension,
depression, Parkinson’s disease,
elderly
menstruation, constipation,
rash, dry mouth, galactorrhea,
gynecomastia, hypotension,
hypertension, tachycardia
Assess for nausea, vomiting,
abdominal distention, and
bowel sounds.
Observe 10 rights in drug
administration.

Assess for allergy to

metoclopramide.

Assess for other

contraindications

Monitor for anxiety,

restlessness, and
extrapyramidal symptoms (EPS)
during IV administration.

Monitor daily pattern of bowel

activity, and stool consistency.

Assess skin for rash.

Monitor diabetic patients

NEUROAID

NAME OF DRUG MODE OF ACTION INDICATION

Generic Name: NeuroAiD boots the brain repair Traditionally used for general
mechanisms by stimulating the health maintenance and
Brand Name: generation of new neural cells strengthening the body.
and favoring the formation of
Classification: new functional neuronal circuits
to repair the damaged areas.
Dosage:
2 capsule

Route:
Oral
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Contraindicated in pregnant Dry mouth, nausea, vomiting, Assess for nausea, vomiting,
and breastfeeding women abdominal discomfort, diarrhea, abdominal distention, and
and headache. bowel sounds.

Observe 10 rights in drug

administration.
Assess for any allergy

Monitor vital sign

Assess for dehydration